None listed
Conditions
Brief summary
The goal of the trial was to determine whether Dose Administration Aids improve veteran outcomes and to characterise which veterans will benefit most from using a DAA. A randomised controlled trial with one year's follow-up was conducted involving Australian war veterans and war widow/ers from selected rural and urban areas of New South Wales, Victoria, Queensland, South Australia and Tasmania. Veterans were randomly allocated to have thier medication packed in a DAA by thier community pharmacy (intervention arm) or to recieve thier medication in the original packaging (control). Due to the nature of the intervention it was not possible to blind participants to the study conditions. The main outcomes were change in severity of illness and adherence.
Interventions
The intervention involved the veteran's Local Medical Officer (LMO) prescribing a DAA in which the veteran's pharmacy packed and dispensed the veteran's medication for the 12 months of the intervention phase.
Sponsors
Quality Medication Care Pty Ltd
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
39 Years to 97 Years
Healthy volunteers
No
Inclusion criteria
(i) Australian veteran or war widow(er)s living in the community; (ii) receiving more than five medicines everyday; or (iii) having three or more concurrent medical conditions. Participation restricted to veterans who are willing to use just one local medical officer (LMO) and one community pharmacy for the duration of the trial and whose LMO and community pharmacy are willing to participate.
Exclusion criteria
In a addition veterans were excluded if they were already using a DAA, were residing in an aged care facility or were participating in other studies with similar aims.
Outcome results
None listed